US agency opens offices in India
This article was originally published in SRA
As part of its efforts to better guarantee the quality of food, drug and medical device imports, the US Food and Drug Administration has set up its first offices in India, in New Delhi and Mumbai1. The agency also recently opened offices in China, the European Union (in Brussels, Belgium), and in Latin America and there are plans to set up offices elsewhere in Latin America and also in the Middle East2,3.
You may also be interested in...
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months.
BMS should find out mid-2020 whether its new MS drug will be approved in the EU.